Literature DB >> 35819710

Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases.

Ami Fukumoto1, Toshiki Terao1, Ayumi Kuzume1, Rikako Tabata1, Takafumi Tsushima1, Daisuke Miura1, Daisuke Ikeda1, Yuya Kamura1, Kentaro Narita1, Masami Takeuchi1, Kosei Matsue2.   

Abstract

Chylous effusion is associated with lymphatic obstruction or leakage in mediastinal or abdominal lymph nodes, and is a rare but troublesome complication in patients with malignant lymphomas. Although there is no standard of care, it is often treated with simultaneous chemotherapeutic and non-chemotherapeutic interventions. Here, we describe the cases of five patients with lymphoma-associated chylothorax with the aim of clarifying an effective treatment strategy. All patients achieved a partial response or better for lymphoma. All patients underwent interventional radiology (IVR) procedures, including lymphangiography (LAG) and thoracic duct embolization (TDE). Complete resolution of chylothorax was eventually achieved by IVR procedures or pleurodesis in all patients. No patients experienced serious adverse events related to LAG/TDE. Treatment of chylous effusion required months for most patients (range: 0.2-4.8 months). Our data suggest that a combination of chemotherapy and LAG/TDE is effective for refractory lymphoma-related chylous effusion.
© 2022. Japanese Society of Hematology.

Entities:  

Keywords:  Chemotherapy; Chylous effusion; Lymphangiography; Lymphoma; Thoracic duct embolization

Mesh:

Substances:

Year:  2022        PMID: 35819710     DOI: 10.1007/s12185-022-03397-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  36 in total

Review 1.  The management of chylothorax.

Authors:  V G Valentine; T A Raffin
Journal:  Chest       Date:  1992-08       Impact factor: 9.410

Review 2.  Aetiology and management of chylothorax in adults.

Authors:  Sukumaran K Nair; Matus Petko; Martin P Hayward
Journal:  Eur J Cardiothorac Surg       Date:  2007-06-18       Impact factor: 4.191

Review 3.  Chylothorax: aetiology, diagnosis and therapeutic options.

Authors:  Emmet E McGrath; Zoe Blades; Paul B Anderson
Journal:  Respir Med       Date:  2009-09-18       Impact factor: 3.415

4.  Etiology of chylothorax in 203 patients.

Authors:  Clinton H Doerr; Mark S Allen; Francis C Nichols; Jay H Ryu
Journal:  Mayo Clin Proc       Date:  2005-07       Impact factor: 7.616

5.  Octreotide to treat postoperative chylothorax after cardiac operations in children.

Authors:  U Pratap; Z Slavik; V D Ofoe; O Onuzo; R C Franklin
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

6.  Octreotide as a therapeutic option for management of chylothorax.

Authors:  Sulaiman A Al-Zubairy; Abdulrazaq S Al-Jazairi
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

7.  Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial.

Authors:  C Cope; R Salem; L R Kaiser
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

8.  The lipoprotein profile of chylous and nonchylous pleural effusions.

Authors:  B A Staats; R D Ellefson; L L Budahn; D E Dines; U B Prakash; K Offord
Journal:  Mayo Clin Proc       Date:  1980-11       Impact factor: 7.616

9.  Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study.

Authors:  C Cope
Journal:  J Vasc Interv Radiol       Date:  1998 Sep-Oct       Impact factor: 3.464

10.  Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients.

Authors:  Gregory J Nadolski; Maxim Itkin
Journal:  Chest       Date:  2013-01       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.